Login / Signup

Computational-based drug repurposing methods in COVID-19.

Yosef Masoudi-Sobhanzadeh
Published in: BioImpacts : BI (2020)
COVID-19, as a newly emerging disease, has disrupted human's different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.
Keyphrases
  • coronavirus disease
  • sars cov
  • adverse drug
  • respiratory syndrome coronavirus
  • drug induced
  • endothelial cells
  • healthcare
  • emergency department
  • pluripotent stem cells